Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: Utility of 'days alive and out of hospital' from epidemiological data

European Journal of Heart Failure

Volumn 12, Issue 5, 2010, Pages 462-468

  Wasywich, Cara A ^a   Gamble, Greg D ^b   Whalley, Gillian A ^b   Doughty, Robert N ^a,b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Epidemiology; Heart failure; Morbidity; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL TIME; ANALYSIS OF VARIANCE; EPIDEMIOLOGY; HEALTH SURVEY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVAL; TIME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; NEW ZEALAND; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79551491683     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq027     Document Type: Article

References (28)

1. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-141.
2. Ryden-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999;246:275-284. (Pubitemid 29426446)
3. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-371. (Pubitemid 35190362)
4. Statistics New Zealand. Demographic Aspects of New Zealand's Ageing Population. 2006; http://www.stats.govt.nz/products-and-services/papers/ demographic-aspectsnz-ageing-population.htm.
5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
6. Writing Committee M Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479.
7. Authors/Task Force M Bassand J-P, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KAA, Hasdai D, Ohman EM, Wallentin L, Wijns W, Guidelines ESCCfP, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Kristensen SD, Widimsky P, McGregor K, Sechtem U, Tendera M, Hellemans I, Gomez JLZ, Silber S, Funck-Brentano C, Document R, Kristensen SD, Andreotti F, Benzer W, Bertrand M, Betriu A, De Caterina R, DeSutter J, Falk V, Ortiz AF, Gitt A, Hasin Y, Huber K, Kornowski R, Lopez-Sendon J, Morais J, Nordrehaug JE, Silber S, Steg PG, Thygesen K, Tubaro M, Turpie AGG, Verheugt F, Windecker S. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-1660. (Pubitemid 47227122)
8. Authors/Task Force M Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Guidelines ESCCfP, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Document R, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Mario CD, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GYH, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945.
9. Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JWT, Capewell S, McMurray JJV. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: a Population Study of 5.1 Million People. Circulation 2009;119:515-523.
10. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to2000. Eur Heart J 2004;25:300-307. (Pubitemid 38295438)
11. Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. Eur Heart J 2009;30:671-678.
12. McLean AS, Eslick GD, Coats AJS. The epidemiology of heart failure in Australia. Int J Cardiol 2007;118:370-374. (Pubitemid 46678240)
13. Fang J, Mensah GA, Croft JB, Keenan NL. Heart Failure-Related Hospitalization in the U. S., 1979 to 2004. J Am Coll Cardiol 2008;52:428-434. (Pubitemid 352040814)
14. Langley J, Stephenson S, Thorpe C, Davie G. Accuracy of injury coding under ICD-9 for New Zealand public hospital discharges. Inj Prev 2006;12:58-61. (Pubitemid 43266240)
15. McAuley S, Rea H, Kumar S, Lamont C. How concordant are hospital discharge codes with physicians' diagnoses? N Z Med J 2004;117:965-966.
16. Kumler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Kober L, Torp-Pedersen C. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008;10:658-660.
17. Polanczyk CA, Rohde LE, Philbin EA, Di Salvo TG. A new casemix adjustment index for hospital mortality among patients with congestive heart failure. Med Care 1998;36:1489-1499. (Pubitemid 128456368)
18. Statistics New Zealand. National Population Estimates: December 2008 quarter. 2008; http://www.stats.govt.nz/store/2009/2002/national-population- estimatesdec2008qtr-hotp.htm.
19. Bonow RO, Bennett S, Casey DE Jr, Ganiats TG, Hlatky MA, Konstam MA, Lambrew CT, Normand S-LT, Pina IL, Radford MJ, Smith AL, Stevenson LW, Bonow RO, Bennett SJ, Burke G, Eagle KA, Krumholz HM, Lambrew CT, Linderbaum J, Masoudi FA, Normand S-LT, Ritchie JL, Rumsfeld JS, Spertus JA. ACC/AHA Clinical Performance Measures for Adults With Chronic Heart Failure: a Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) Endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2005;46:1144-1178. (Pubitemid 41316528)
20. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy C, Young JB, for the O-HFIaH. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. J Am Med Assoc 2007;297:61-70. (Pubitemid 46041727)
21. Gheorghiade M, Adams KF, Cleland JGF, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the acute heart failure syndromes international working group. Am Heart J 2009;157:957-970.
22. Allen LA, Hernandez AF, O'Connor CM, Felker GM. End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol 2009;53:2248-2258.
23. Cleland JGF. How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey. Eur J Heart Fail 2002;4:243-247. (Pubitemid 35190346)
24. Cleland JGF, Charlesworth A, Lubsen J, Swedberg K, Remme WJ, Erhardt L, Di Lenarda A, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson PA. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the 'Patient Journey') in patients with heart failure: a Report from the Carvedilol Or Metoprolol European Trial (COMET). J Am Coll Cardiol 2006;47:1603-1611.
25. Nieminen MS, Cleland JG, Eha J, Belenkov Y, Kivikko M, Poder P, Sarapohja T. Oral levosimendan in patients with severe chronic heart failure-the PERSIST study. Eur J Heart Fail 2008;10:1246-1254.
26. Stevenson LW, Lewis E. Mapping the journey. J Am Coll Cardiol 2006;47:1612-1614.
27. NHS Institute for Innovation and Improvement. Focus on: Heart Failure. 2009; www.institute.nhs.uk/index.php?option=com-joomcart&Itemdi= 194&main-page=document-product-info&production-id=547.
28. Hobbs FDR. Delivering quality and value in heart failure. BMJ 2009;338:b1672.